News | July 31, 2023
Biogen to acquire Reata Pharmaceuticals
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Marks the World Head & Neck Cancer Day at the OCTF Conference
Uses a simple mechanical approach for removing intrauterine tissues
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
First of its kind screening for Glaucoma at grass root level over 10k screened already
Subscribe To Our Newsletter & Stay Updated
